News
GTI Bets on Its Own Stock, Again
CHICAGO – Green Thumb Industries Inc. announced that its board of directors had authorized a $50 million share repurchase program – the company's third consecutive buyback initiative since 2023. Under the new program, Green Thumb is authorized to repurchase up to 10,364,640 subordinate voting shares over the following 12 months. Purchases can be made on ...
Vireo Growth Completes M3 Wellness Acquisition
MINNEAPOLIS – Vireo Growth Inc. announced the completion of its acquisition of M3 Wellness, a retail Cannabis dispensary in Hawthorne, NV. Structured as an indirect asset purchase from M3 Wellness, LLC under an agreement signed in June, 2026, the transaction closed after the Nevada Cannabis Compliance Board granted its regulatory sign-off. Total consideration for the ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – Big Pharma stopped dipping its toe and dove in headfirst. A $3.8 billion psychedelic acquisition closed. A hostile Cannabis takeover escalated into a full public war of facts and figures, with a December deadline for shareholders to decide. Operators pushed into new states, capital markets moved, and regulators in Virginia, New York, ...
Safe Harbor Equity & Highly Capitalized Network Announce Strategic Capital Advisory & Investor Outreach Partnership
LOS ANGELES — September 8, 2026 — Safe Harbour Equity, Inc. and Highly Capitalized Network-HCN today announced a strategic partnership to help carefully selected companies strengthen their investment propositions, reach qualified investors and build the relationships required to raise capital. The partnership unites two complementary capabilities. Safe Harbour Equity contributes an extensive investor and professional ...
Vireo Growth Settles Altmore Claim with Share Issuance
MINNEAPOLIS – Vireo Growth Inc. announced that it will issue 462,963 subordinate voting shares as part of a settlement with SHWZ Altmore, LLC and Altmore Debt I, LP – the entities the company collectively refers to as Altmore in its public filing. The shares represent consideration for Vireo's acquisition of secured obligations and related liens ...
Public Opinion Fires Up Support for Cannabis in NC
RALEIGH – A large majority of North Carolina adults support legalizing adult-use Cannabis for medical use, and a smaller but clear majority backs recreational legalization as well, according to an Elon University Poll. The survey also found that most residents want hemp-derived THC products [seltzers, gummies, and similar items] to stay on shelves, but with ...
Xylo Bio Advances Its Lead Into First-In-Human Clinical Trial
BOSTON – Xylo Bio confirmed that the first participants have been dosed in a Phase 1 clinical trial of XYL-1001, the company's lead drug candidate targeting major depressive disorder (MDD). The trial is underway in Australia, and it marks the company's transition from a preclinical to a clinical-stage running. The study is structured as a ...
TerrAscend Closes Acquisition of Aunt Mary’s in NJ
TORONTO – TRENTON – TerrAscend Corp. confirmed it has closed its previously announced transaction with Aunt Mary's Dispensary LLC, a Cannabis retail operation in Hunterdon County, NJ. The deal marks the company's fifth retail location in the Garden State. The transaction was first signed in June and structured at a total consideration of $9 million. ...
Medical Saints Targets Christina Lake Cannabis in $18M Deal
VANCOUVER, BC – Christina Lake Cannabis Corp. (CLC) has received an unsolicited $18 million cash purchase offer for substantially all of its assets from Ontario licensed producer Medical Saints Ltd. setting up a competing transaction scenario for the company's board of directors. The proposed asset sale represents a structural departure from an earlier non-binding letter ...
Aurora Reaffirms Growth Outlook on European Strength
EDMONTON – Aurora Cannabis Inc. issued a business update, reaffirming guidance for sequential growth in net revenue and adjusted EBITDA in fiscal Q2 2027. The company cited the integration of Safari Flower Company and continued strength in Germany and Poland as the primary basis for that confidence. Aurora closed its C$26.5 million acquisition of Safari ...
Aurora and Curaleaf Trade Statements in Ongoing Bid Dispute
EDMONTON - STAMFORD – Aurora Cannabis and Curaleaf Holdings continued their public exchange over Curaleaf’s unsolicited takeover offer for the Canadian medical Cannabis company. Aurora issued a statement responding to Curaleaf’s regulatory filing, while Curaleaf released a letter to Aurora shareholders and scheduled a direct Q&A session with its CEO. Aurora responded to Curaleaf’s application ...
Definium Achieves Second Positive Phase 3 for GAD
NEW YORK – Definium Therapeutics Inc. released topline data from its second pivotal Phase 3 trial (Panorama study) of DT120 in generalized anxiety disorder (GAD), adding to earlier positive findings in the same indication and in major depressive disorder (MDD). The trial evaluated a single dose of DT120, an orally disintegrating tablet formulation of lysergide ...
High Tide Reports Q3 2026 Financial Results
CALGARY – High Tide Inc. posted revenue of $198.8 million for the three months ended July 31, 2026, a 33% increase from the same period last year and the fifth consecutive quarterly record. Gross profit came in at $52.7 million, up 32% year-over-year, with gross margin holding steady at 27%. Adjusted EBITDA reached $16.2 million, ...
Curaleaf Escalates Aurora Fight, Asks Alberta Regulator to Freeze Share Sales
STAMFORD – Curaleaf Holdings Inc. submitted a formal application to the Alberta Securities Commission (ASC), seeking to halt Aurora Cannabis's at-the-market share issuance program while Curaleaf's offer to acquire all outstanding Aurora shares remains outstanding. The company has simultaneously requested an expedited hearing, as disclosed in the official company press release. The formal bid – ...
Dutch Cannabis Supply Pilot Delivers Lower Prices and a Fuller Shelf
AMSTERDAM – A report published by the Trimbos Institute, RAND Europe, and Breuer&Intraval compared ten municipalities where coffeeshops sell exclusively licensed-grown Сannabis against ten operating under the country's traditional tolerance policy. The program launched April 7, 2025. The first follow-up covers data through the first quarter of 2026. The sharpest early change showed up in ...
Cannara Secures Upgraded $80M Credit Line
MONTREAL – Cannara Biotech Inc. announced that its operating subsidiary has entered into an amended and restated syndicated credit agreement with Bank of Montreal (BMO) and The Toronto-Dominion Bank (TD), establishing $80 million in committed borrowing capacity, a $30 million increase from the approximately $50 million accessible before refinancing. The new structure splits the facility ...
Virginia Unveils Draft Rules for Adult-Use Cannabis Market
RICHMOND – The Virginia Cannabis Control Authority (CCA) released an 80-plus-page draft regulatory framework for the state's forthcoming adult-use market – the first detailed set of proposed rules since the General Assembly authorized commercial sales earlier this year. Licensed retailers are scheduled to open their doors on July 1, 2027. The document spans every stage ...
Metrc Rolls Out Compliance Events for New York Cannabis Operators
NEW YORK – Track-and-trace provider Metrc announced a pair of statewide User Exchange events in New York, one in New York City on September 14 and another in Syracuse on September 16, designed to help Cannabis licensees sharpen their compliance practices and extract greater operational value from the state's seed-to-sale tracking system. The events will ...
Eli Lilly Completes Acquisition of AtaiBeckley
INDIANAPOLIS – Eli Lilly & Co. has closed its acquisition of AtaiBeckley Inc., the New York-based biopharmaceutical company developing psychedelic-derived therapies for treatment-resistant mental health conditions. The transaction cleared its final U.S. regulatory checkpoint when the premerger antitrust review waiting period expired on August 28, completing the last material hurdle before formal close. Under the ...
Curaleaf Fires Back at Aurora Claims with Detailed Fact Sheet
STAMFORD – Curaleaf Holdings Inc. released a 14-point public fact sheet taking direct aim at what it described as misleading statements Aurora Cannabis Inc. has circulated in opposition to Curaleaf's unsolicited bid to acquire the company. The hostile takeover bid values Aurora at approximately US$272 million (C$374.8 million). Aurora's board unanimously rejected the proposal and ...
Cannaflex Opens European Export Route
RABAT – Moroccan operator Cannaflex has secured EU-GMP compliance verification for the commercial export of medical Cannabis starting materials to Switzerland and broader European markets, marking an operational milestone for the Kingdom's legal framework. Working in collaboration with Swiss-based Pharmaserv AG, the documented supply pathway links GACP-certified cultivation in Morocco's historic Rif region directly with ...
Opus Consulting Appointed Receiver for PharmaCann Maryland Assets
BALTIMORE – Business advisory firm Opus Consulting, acting through President Jacques Santucci, has been appointed court receiver for the Maryland assets of PharmaCann, initiating a court-approved structured bidding process to sell the company’s state-issued licenses and operational infrastructure. The receivership, ordered by the Circuit Court for Montgomery County, MD, follows an action initiated by Argent ...
Grown Rogue Launches Cultivation Ops in Minnesota
MEDFORD – Grown Rogue International Inc. officially began cultivation operations at its Fridley, Minnesota facility, nine months after first securing the location in December 2025. Phase I puts roughly 8,000 sq. feet of flowering canopy into production. The first indoor craft flower to come out of a purpose-built, multi-state-operator facility inside the state. The building ...
NEWS: Psilocybin Could Help Prevent Debilitating Nerve Damage Caused by Chemotherapy
AUSTIN – A new study from The University of Texas MD Anderson Cancer Center suggests that psilocybin, the psychedelic compound found in certain mushrooms, could eventually help prevent one of chemotherapy’s most painful and persistent side effects. The research, published September 3 in the journal Science, examined whether psilocybin could prevent chemotherapy-induced peripheral neuropathy, commonly known ...
Elixinol Offloads Its US Hemp Business to Ananda Health
SYDNEY – Australian Elixinol Wellness Limited has entered into a binding asset purchase agreement with Ananda Health to sell its wholly-owned subsidiary, Elixinol LLC, effectively exiting the United States hemp market. Under the transaction terms, Ananda Health will acquire the assets, intellectual property, and operational goodwill of Elixinol’s U.S. operations for a total headline consideration ...
